Professional Bio
Andrew D. Goodman, MD is Professor of Neurology, Chief of the Neuroimmunology Unit, and Director of the Multiple Sclerosis Center at the University of Rochester.
Dr. Goodman is a graduate of Rutgers College and the University of Medicine and Dentistry of New Jersey; he did residency training in internal medicine and neurology at Mt. Sinai Medical Center in New York City. He completed a research fellowship in the Neuroimmunology Branch at the National Institutes of Health, Bethesda, Maryland.
Numerous publications reflect his interests in clinical and experimental therapeutics research as well as the immunology and virology of multiple sclerosis. Dr. Goodman has been principal investigator and a member of national and international steering committees for numerous clinical trials of new therapies for multiple sclerosis.
Dr. Goodman is a past Chair of the Multiple Sclerosis Section of the American Academy of Neurology. He has served the National Multiple Sclerosis Society as Deputy Medical Officer, Co-Chair of the Long-term Care Committee, member of the Client Education Committee, and member of the Executive Committee of the National Clinical Advisory Board.
| Fellow, American Academy of Neurology |
2005 |
| Impact Presentation Award, Congress of the European Committee for Treatment and Research in Multiple Sclerosis | Vienna |
2004 |
| Senior Faculty Award | University of Rochester Department of Neurology | Rochester, NY |
2003 |
| Chair, Multiple Sclerosis Section | American Academy of Neurology |
1999 - 2000 |
| Chair-elect, Multiple Sclerosis Section | American Academy of Neurology |
1998 - 1999 |
| Named in Best Doctors in America |
1998 - Present |
| University of Rochester Neurology Resident Faculty Teaching Award | Rochester, NY |
1997 |
| Named in Best Doctors in America: Northeast. |
1996 - Present |
| Chief Neurology Resident | Mount Sinai Medical Center |
1982 - 1983 |
| Alpha Omega Alpha |
1979 |
| A.B. with Distinction in Biochemistry |
1974 |
| Henry Rutgers Scholar |
1973 - 1974 |
| Inductee, Volunteer Hall of Fame | US National Multiple Sclerosis Society | New Orleans, LA |
2001 |
2011 May
Samkoff LM, Goodman AD. "Symptomatic management in multiple sclerosis." Neurologic clinics. 2011 May 0; 29(2):449-63. |
2010 Nov
Morrow SA, O'Connor PW, Polman CH, Goodman AD, Kappos L, Lublin FD, Rudick RA, Jurgensen S, Paes D, Forrestal F, Benedict RH. "Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks." Multiple sclerosis (Houndmills, Basingstoke, England). 2010 Nov 0; 16(11):1385-92. Epub 2010 Aug 25. |
2010 Oct
Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR, . "A phase 3 trial of extended release oral dalfampridine in multiple sclerosis." Annals of neurology. 2010 Oct 0; 68(4):494-502. |
2010 Sep
Rudick RA, O'Connor PW, Polman CH, Goodman AD, Ray SS, Griffith NM, Jurgensen SA, Gorelik L, Forrestal F, Sandrock AW, E Goelz S. "Assessment of JC virus DNA in blood and urine from natalizumab-treated patients." Annals of neurology. 2010 Sep 0; 68(3):304-10. |
2010 Sep
Herrmann DN, O'Connor AB, Schwid SR, Da Y, Goodman AD, Rafferty J, Donahue S, Dworkin RH. "Broadening the spectrum of controls for skin biopsy in painful neuropathies." Muscle & nerve. 2010 Sep 0; 42(3):436-8. |
